HYPERBARIC OXYGEN THERAPY FOR Asthma
Hyperbaric oxygen therapy (HBOT) has been found to be an effective treatment for asthma, a chronic lung condition affecting millions of people worldwide. HBOT works by delivering high-dose oxygen at higher-than-normal atmospheric pressures, which helps improve the airway function in people with asthma. This increased availability of oxygen causes the body's immune system to respond more quickly and effectively to allergens and other triggers that can induce an asthma attack. As such, it is seen as a useful tool for controlling the symptoms of asthma and reducing the frequency and severity of attacks.
Studies have shown that HBOT can reduce symptoms such as wheezing, coughing, difficulty breathing, chest tightness, and shortness of breath within just a few weeks; these effects are further enhanced after multiple treatments. Other benefits include improved lung capacity and decreased medication usage. In addition, some studies have noted that HBOT can help reduce inflammation in the bronchial tubes associated with airway constriction during an asthma attack. Even long-term remission from asthma symptoms has been documented in some cases.
In addition to its therapeutic use in treating asthma, HBOT has also been found to be beneficial for athletes who suffer from exercise-induced bronchoconstriction (EIB). A single session of HBOT has been shown to reduce this type of airway narrowing by up to 60%, providing athletes with greater freedom of movement during physical exertion and significantly improving performance levels. Similarly, postoperative patients undergoing respiratory procedures have also found relief through HBOT treatments due to its anti-inflammatory properties.
For individuals looking for a safe and natural treatment option for their asthma or EIB symptoms, hyperbaric oxygen therapy offers promising potential as an alternative or supplementary therapy. The fact that HBOT is noninvasive makes it particularly appealing compared with other forms of treatment.
Contact Thrive Hyperbarics today.